Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PSD502 for premature ejaculation
ISRCTN57186091Phase 3Completed
- Sponsor
- Plethora Solutions
- Start
- Oct 2007
- Modality
- Small Molecules, Drug Delivery Systems
01
Overview
Phase 3, randomised, double-blind trial in premature ejaculation (PE) comparing PSD502 with Placebo (2 arms). Primary endpoints: Change in mean intravaginal ejaculatory latency time and Change in Index of Premature Ejaculation domains. Started Oct 2007; status: completed.
02
Drugs
lidocaine + prilocaine
03
Conditions
premature ejaculation (PE)
Beyond the preview
Go deeper on ISRCTN57186091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN57186091.